PPP
Parabilis Medicines, Inc.
No trades
No trades
Compare with Parabilis Medicines, Inc.
−145.89 M USD
0.00 USD
84.81 M
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
Details
Sector
Industry
CEO
Mathai Mammen
Website
Headquarters
Cambridge
Founded
2015
IPO date
Jun 10, 2026
IPO offer price
20.00 USD
ISIN
US6989551014
CUSIP
698955101
FIGI
BBG00KXR8FS7
Identifiers
ISIN US6989551014
Fog Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops cell-penetrating miniproteins (CPMPs), which are specifically designed to target cancer-causing proteins inside cancer cells and neutralize them. The company was founded by Gregory L. Verdine, WeiQing Zhou and David Philip Lane in 2015 and is headquartered in Cambridge, MA.
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Frequently asked questions
The current price of PBLS is 35.67 USD — it has increased by 2.58% in the past 24 hours. Watch Parabilis Medicines, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Parabilis Medicines, Inc. stocks are traded under the ticker PBLS.
PBLS stock has risen by 2.19% compared to the previous week, the month change is a 23.26% rise, over the last year Parabilis Medicines, Inc. has showed a 6.96% increase.
We've gathered analysts' opinions on Parabilis Medicines, Inc. future price: according to them, PBLS price has a max estimate of 45.00 USD and a min estimate of 40.00 USD. Watch PBLS chart and read a more detailed Parabilis Medicines, Inc. stock forecast: see what analysts think of Parabilis Medicines, Inc. and suggest that you do with its stocks.
PBLS reached its all-time high on Aug 12, 2026 with the price of 37.83 USD, and its all-time low was 24.51 USD and was reached on Jun 15, 2026. View more price dynamics on PBLS chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
PBLS stock is 6.96% volatile and has beta coefficient of −0.49. Track Parabilis Medicines, Inc. stock price on the chart and check out the list of the most volatile stocks — is Parabilis Medicines, Inc. there?
Today Parabilis Medicines, Inc. has the market capitalization of 4.42 B, it has increased by 3.73% over the last week.
Yes, you can track Parabilis Medicines, Inc. financials in yearly and quarterly reports right on TradingView.
Parabilis Medicines, Inc. is going to release the next earnings report on Dec 2, 2026. Keep track of upcoming events with our Earnings Calendar.
PBLS earnings for the last quarter are −2.32 USD per share, whereas the estimation was −0.17 USD resulting in a −1.31 K% surprise. The estimated earnings for the next quarter are −0.35 USD per share. See more details about Parabilis Medicines, Inc. earnings.
Parabilis Medicines, Inc. revenue for the last quarter amounts to 0.00 USD, despite the estimated figure of 16.67 M USD. In the next quarter, revenue is expected to reach 0.00 USD.
PBLS net income for the last quarter is −45.32 M USD, while the quarter before that showed −38.33 M USD of net income which accounts for 0.00% change. Track more Parabilis Medicines, Inc. financial stats to get the full picture.
No, PBLS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, PBLS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Parabilis Medicines, Inc. stock right from TradingView charts — choose your broker and connect to your account.